Hyperammonemia after high-dose chemotherapy and stem cell transplantation

Bone Marrow Transplantation

Volumn 26, Issue 3, 2000, Pages 343-345

  Frere, P ^a   Canivet, J L ^a   Gennigens, C ^a   Rebeix, J P ^a   Fillet, G ^a   Beguin, Y ^a,b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Hyperammonemia; Multiple myeloma; Peripheral blood stem cell transplantation

Indexed keywords

AMPHOTERICIN B; CARNITINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; FLUCYTOSINE; FLUMAZENIL; INTERFERON; LACTULOSE; MELPHALAN; NEOMYCIN; PREDNISOLONE; VINCRISTINE;

ADULT; ARTICLE; CANDIDIASIS; CASE REPORT; CONFUSION; DIET; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPERAMMONEMIA; MULTIPLE MYELOMA; PRIORITY JOURNAL;

EID: 0033859130     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702485     Document Type: Article

References (19)

1. Mitchell RB, Wagner JE, Karp JE et al. Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases. Am J Med 1988; 85: 662-667.
2. Davies SM, Szabo E, Wagner JE et al. Idiopathic hyperammonemia: a frequently lethal complication of bone marrow transplantation. Bone Marrow Transplant 1996; 17: 1119-1125.
3. Leonard JV, Kay JDS. Acute encephalopathy and hyperammonaemia complicating treatment of acute lymphoblastic leukaemia with asparaginase. Lancet 1986; i: 162-163.
4. Shi-Rong X, Er-Gu Y, Zuo-Ren D et al. Plasma ammonia in patients with acute leukemia. Chin Med J 1992; 105: 713-716.
5. Jürgens P. New aspects on etiology, biochemistry, and therapy of portal systemic encephalopathy: a critical survey. Nutrition 1997; 13: 560-570.
6. Watson AJ, Chambers T, Karp JE et al. Transient idiopathic hyperammonaemia in adults. Lancet 1985; ii: 1271.
7. Felig DM, Brusilow SW, Boyer JL. Hyperammonemic coma due to parenteral nutrition in a woman with heterozygous ornithine transcarbamylase deficiency. Gastroenterology 1995; 109: 282-284.
8. Sharp RA, Lang CC. Hyperammonaemic encephalopathy in chronic myelomonocytic leukemia. Lancet 1987; i: 805.
9. Butterworth RF, Giguere JF, Michaud J et al. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol 1987; 6: 1-12.
10. Felipo V, Hermenegildo C, Montolin C et al. Neurotoxicity of ammonia and glutamate: molecular mechanisms and prevention. Neurotoxicology 1998; 19: 675-681.
11. Tse N, Cederbaum S, Glaspy JA. Hyperammonemia following allogeneic bone marrow transplantation. Am J Hematol 1991; 38: 140-141.
12. Oppong KNW, Al-Mardini H, Thick M, Record CO. Oral glutamine challenge in cirrhotics pre-and post-liver transplantation: a psychometric and analyzed EEC study. Hepatology 1997; 26: 870-876.
13. Semana DS, Huet F, Gouyon J-B et al. Use of peritoneal dialysis, continuous arteriovenous hemofiltration, and continuous arteriovenous hemodiafiltration for removal of ammonium chloride and glutamine in rabbits. J Pediatr 1995; 126: 742-746.
14. Therrien G, Rose C, Butterworth J, Butterworth RF. Protective effect of L-carnitine in ammonia-precipitated encephalopathy in the portacaval shunted rat. Hepatology 1997; 25: 551-556.
15. Beversdorf D, Allen C, Nordgren R. Valproate induced encephalopathy treated with carnitine in an adult. J Neuro Neurosurg Psych 1996; 61: 211.
16. Meier R, Gyr K. Treatment of hepatic encephalopathy (HE) with the benzodiazepine antagonist flumazenil: a pilot study. Eur J Anaesth 1988: S2: 139-146.
17. Schafer DF, Jones EA. Hepatic encephalopathy and the γ-aminobutyric-acid neurotransmitter system. Lancet 1982; i: 18-20.
18. Mullen KD, Martin JV, Mendelson WB et al. Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy? Lancet 1988; i: 457-459.
19. Pomier-Layrargues G, Giguère JF, Lavoie J et al. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial. Hepatology 1997; 19: 32-37.